Richard H. Tullis
Geen lopende functies
Profiel
Richard H.
Tullis was the founder of Synthetic Genetics (1985) where he held the title of President & Chief Executive Officer.
He is also the founder of Molecular Biosystems, Inc. Dr. Tullis's former jobs include Interim Chief Executive Officer at Genetic Vectors, Inc. and Director at Verthermia, Inc. He was also the Chief Scientific Officer at Aethlon Medical, Inc. from 2000 to 2016.
Dr. Tullis earned a doctorate degree from the University of California San Diego.
Eerdere bekende functies van Richard H. Tullis
| Bedrijven | Functie | Einde |
|---|---|---|
| AETHLON MEDICAL, INC. | Hoofd Techniek/Wetenschap/O&O | 09-02-2016 |
Verthermia, Inc.
 Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Directeur/Bestuurslid | - |
Genetic Vectors, Inc.
 Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | President | - |
Synthetic Genetics
 Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Oprichter | - |
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Oprichter | - |
Opleiding van Richard H. Tullis
| University of California San Diego | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AETHLON MEDICAL, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Genetic Vectors, Inc.
Genetic Vectors, Inc. Pharmaceuticals: MajorHealth Technology Genetic Vectors, Inc. is a biotechnology company, which supplies genetic engineering tools and analytical kits to the biotechnology and molecular biology markets. Its products allow biopharmaceutical companies to test for biopharmaceutical product purity in compliance with regulatory standards. The company is currently marketing the EpiDNA product line as a quality control tool for the biopharmaceutical industry. Its EasyID genetic screening products are designed to study disease risk assessment, drug resistance, and drug responsiveness. The company was founded by Mead M. McCabe on December 28, 1991 and is headquartered in Aventura, FL. | Health Technology |
Synthetic Genetics
Synthetic Genetics Miscellaneous Commercial ServicesCommercial Services Part of Ngen, Inc., Synthetic Genetics is an American company that provides a broad line of modified obligonucleotides, including research probes to the research market. The company was founded by Richard H. Tullis. Synthetic Genetics was acquired by Epoch Biosciences, Inc., a subsidiary of Ngen, Inc. from Immune Complex Corp. on November 21, 2000 for $3.10 million. | Commercial Services |
Verthermia, Inc.
Verthermia, Inc. Miscellaneous Commercial ServicesCommercial Services Verthermia, Inc. develops cancer treatment which induces Whole Body Hyperthermia (WBHT) by directly heating circulating blood. It specializes in medical devices and cancer therapy. The company was founded in 2012 and is headquartered in San Jose, CA. | Commercial Services |
